Solve M.E.’s 2026 State of the Union: From Protecting Progress to Building What’s Next
In our 2026 State of the ME/CFS Union Address, Solve M.E. leadership shared a vision
October 21, 2026
In our 2026 State of the ME/CFS Union Address, Solve M.E. leadership shared a vision
This week, Solve submitted public comments on proposed changes to the Centers for Disease Control
Solve is now accepting applications for the Ramsay Research Grant Program! This year marks the
On October 20th at 1 pm PT / 4 pm ET, Solve M.E. is bringing our
BioVie announced promising results from the ADDRESS-LC trial assessing the potential impact of the drug
The National Institute of Allergy and Infectious Diseases (NIAID) has proposed a reorganization that would
Could IVO-21 Lead to a New ME/CFS Mitochondrial Treatment? In May 2026, Solve selected Dr.
Today, we’re saying a big thank you to our Members of Congress. By passing a
Dr. Rob Wüst, physiology professor at the Vrije de Universiteit (Netherlands) and winner of a
Dr. David Esteban is a professor of biology at Vassar College. He specializes in understanding
We wanted to provide an update on Solve M.E.’s recent advocacy campaign opposing the proposed
This quarter’s summaries highlight several studies examining the biological mechanisms of ME/CFS and Long Covid,
